L icensing ourselves to hyperbole, sepsis may be one of the most diverse syndromes in the modern clinical vocabulary (1) . For starters, it is a syndrome with etiologic agents not only across three taxonomic kingdoms of life (bacteria, protozoa, and fungi) but also outside of the taxonomy of life (viruses). Multiplying the possible flavors of sepsis, many of these pathogens can infect a variety of human tissues, and each infective episode can in turn induce different combinations of systemic inflammatory responses and distant organ failures. Just how many flavors of sepsis can there be? As a simple thought experiment, let us ignore the rainbow of etiologic agents, assume one source of infection per sepsis episode and narrow the field of organ dysfunctions to five. To get the total number of sepsis combinations under these stipulations, we multiply the five infection sources by the 11 different combinations of systemic inflammatory response syndrome (SIRS) criteria that meet a definition of sepsis by the 31 combinations of organ dysfunctions ( Fig. 1) . This gives us 1,705 shades of sepsis, admittedly only the tip of the iceberg given that we have ignored the myriad of etiologic agents. Yet, like choosing which variation of beige to paint your dining room, the important question is whether there is any meaningful difference between these myriad tones of sepsis? The article published in this issue of Critical Care Medicine by Shankar-Hari et al (2) adds to a body of evidence suggesting that there "is" a meaningful difference.
To summarize, the article is a cohort study of the 241,603 adults admitted with a diagnosis of infection to a general critical care unit in England from 2000 to 2012. Systemic inflammatory response and organ dysfunction criteria were extracted from physiologic data within the first 24 hours of critical care admission and hospital mortality was the primary outcome. The study uses data from the Case Mix Programme, a high quality, professionally and independently maintained database of nearly every patient of every general critical care unit in the United Kingdom (3). The analyses examine the unadjusted hospital mortality of sepsis from many different angles: source of infection, quantity and combination of SIRS criteria, and quantity and combination of organ dysfunctions. The results display a wide range of hospital mortality along every facet. For source of infection, hospital mortality was lowest for genitourinary infections (19.4%) and highest for cardiovascular infections (44.2%). For SIRS criteria, even within groupings of two and three total criteria met within the first 24 hours of critical care admission, different combinations were associated with wide within-group variation in unadjusted hospital mortality (from approximately 20-40%, estimating from the graphs). Similarly, among different combinations of organ dysfunctions, there is a considerable range of unadjusted hospital mortality rates. From this data, the investigators create four risk categories of organ dysfunction combinations, grouped by the associated hospital mortality rates rather than the sum or physiologic relationships of organ dysfunctions. They demonstrate that within each risk category, hospital mortality has followed a similar downward trend from 2000 to 2012, an observation that increases confidence in the notion that overall sepsis mortality is improving due to changes in care rather than increases in diagnosis of less severe cases. Furthermore, the investigators use these risk categories to hypothesize an explanation as to why the hospital mortality from sepsis in England was on average 1.5 times higher than that reported in a well-known study over the same time period in Australia and New Zealand (4) . Their analyses suggest that the sepsis case mix in England represents a higher risk case mix than that found in Australia and New Zealand. However, while they illustrate that overall mortality reported in Australia and New Zealand is similar to the mortality from risk category 2 sepsis in England, we do not see the risk categories of the Australia and New Zealand data, limiting any direct comparisons.
The study by Shankar-Hari et al (2) graphically depicts the wide variations in unadjusted hospital mortality of a wide variety sepsis syndromes defined by various combinations of infection source, SIRS criteria, and organ dysfunctions. Although this is an important and well-presented reminder of the significant variety under the umbrella of sepsis, many of the concepts are not new. The notion that increasing numbers of abnormal vital signs and organ dysfunctions was associated with increased mortality in sepsis was demonstrated in the early clinical studies of sepsis from the mid-1990s (5-7) . Furthermore, the effects of different combinations and severities of acute physiology on the mortality of critically ill sepsis patients have been skillfully modeled since the original Sepsis-Related Organ Failure Assessment (SOFA) score in 1996 (8) . Given that the SOFA is advocated as a defining feature of sepsis among the critically ill in the Third International Consensus Guidelines and that Dr. Shankar-Hari was the lead investigator on the development of these new definitions, it is unclear why the SOFA score was not employed in the present work to explore the variations in mortality (1, 9) . Instead, we are presented with a new and unvalidated risk categorization based on combinations of organ dysfunctions that may be less useful in benchmarking and comparing sepsis mortality across nations and healthcare systems than a more well-known, widely-used, and validated model, of which SOFA is only one of many. Therefore, although this article clearly demonstrates the importance of case-mix adjustment and severity of illness adjustment in comparing sepsis outcomes, the Third Consensus Guidelines' employment of the SOFA score may offer a more cohesive method for both defining sepsis and adjusting for case mix based on acute physiology.
As Shankar-Hari et al (2) allude to in their article's title, the issue of utilizing a method for mortality risk adjustment specific to sepsis is of utmost importance when comparing sepsis outcomes across boundaries of institution, nation, and time. In considering international comparisons, it is challenging to conceive of sepsis outcome benchmarks that could be globally generalizable given this inherently heterogeneous syndrome and the wide variety of regional variation in available resources, endemic pathogens, and prevalent comorbidities. Furthermore, this provides an important frame of reference for understanding the difficulty in finding effective medical interventions in sepsis and testing them in international multicenter trials. Additionally, these issues of comparison and benchmarking are of importance even within a single country. This may currently be very salient to readers from the United States, as the recognition and treatment of sepsis has now become a core quality measure for assessing hospital performance in this country (10) . Particularly in benchmarking, assessing and comparing the effects of the core measures on sepsis mortality across time and healthcare systems, the issue of whether or not there is a method for mortality risk adjustment "specific" to sepsis will become critically important. Despite these challenges, it is exciting to be witness to these changes in the field of sepsis that may be beginning to move from increasing global awareness to improving global quality of care. where n is the number of distinct items in a given set, and r is one of the range of numbers of items selected from that set. For the systemic inflammatory response syndrome (SIRS), for example, n = 4 SIRS criteria and r = 2, 3, or 4 for the number of criteria we can select from this set to meet the definition of sepsis.
